Emmett, L., Papa, N., Subramaniam, S., Crumbaker, M., Joshua, A. M., Nguyen, A., Weickhardt, A. J., Lee, S. T., Ng, S., Francis, R. J., Goh, J. C., Pattison, D. A., Tan, T. H., Kirkwood, I. D., Hofman, M. S., Sandhu, S., Martin, A. J., Thomas, H., Davis, I. D., Stockler, M. R. (2025). Predictive and prognostic value of baseline PSMA-PET total tumor volume and SUV mean within ENZA-p, a randomized phase II trial of enzalutamide versus enzalutamide plus [ 177 Lu] Lu-PSMA-617 (ANZUP1901).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5011